225 related articles for article (PubMed ID: 21892137)
1. Orientation-specific signalling by thrombopoietin receptor dimers.
Staerk J; Defour JP; Pecquet C; Leroy E; Antoine-Poirel H; Brett I; Itaya M; Smith SO; Vainchenker W; Constantinescu SN
EMBO J; 2011 Sep; 30(21):4398-413. PubMed ID: 21892137
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation.
Matthews EE; Thévenin D; Rogers JM; Gotow L; Lira PD; Reiter LA; Brissette WH; Engelman DM
FASEB J; 2011 Jul; 25(7):2234-44. PubMed ID: 21402716
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation.
Defour JP; Itaya M; Gryshkova V; Brett IC; Pecquet C; Sato T; Smith SO; Constantinescu SN
Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2540-5. PubMed ID: 23359689
[TBL] [Abstract][Full Text] [Related]
4. His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor.
Leroy E; Defour JP; Sato T; Dass S; Gryshkova V; Shwe MM; Staerk J; Constantinescu SN; Smith SO
J Biol Chem; 2016 Feb; 291(6):2974-87. PubMed ID: 26627830
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling.
Wang Q; Sun R; Wu L; Huang J; Wang P; Yuan H; Qiu F; Xu X; Wu D; Yu Y; Liu X; Zhang Q
Int J Biochem Cell Biol; 2013 Dec; 45(12):2852-63. PubMed ID: 24144576
[TBL] [Abstract][Full Text] [Related]
6. An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.
Staerk J; Lacout C; Sato T; Smith SO; Vainchenker W; Constantinescu SN
Blood; 2006 Mar; 107(5):1864-71. PubMed ID: 16249382
[TBL] [Abstract][Full Text] [Related]
7. NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains.
Kim MJ; Park SH; Opella SJ; Marsilje TH; Michellys PY; Seidel HM; Tian SS
J Biol Chem; 2007 May; 282(19):14253-61. PubMed ID: 17369254
[TBL] [Abstract][Full Text] [Related]
8. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.
Seubert N; Royer Y; Staerk J; Kubatzky KF; Moucadel V; Krishnakumar S; Smith SO; Constantinescu SN
Mol Cell; 2003 Nov; 12(5):1239-50. PubMed ID: 14636581
[TBL] [Abstract][Full Text] [Related]
9. Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN.
Elf S; Abdelfattah NS; Baral AJ; Beeson D; Rivera JF; Ko A; Florescu N; Birrane G; Chen E; Mullally A
Blood; 2018 Feb; 131(7):782-786. PubMed ID: 29288169
[TBL] [Abstract][Full Text] [Related]
10. Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.
Lee TS; Kantarjian H; Ma W; Yeh CH; Giles F; Albitar M
PLoS One; 2011; 6(8):e23396. PubMed ID: 21858098
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers.
Defour JP; Leroy E; Dass S; Balligand T; Levy G; Brett IC; Papadopoulos N; Mouton C; Genet L; Pecquet C; Staerk J; Smith SO; Constantinescu SN
Elife; 2023 Jun; 12():. PubMed ID: 37338955
[TBL] [Abstract][Full Text] [Related]
12. [Single molecule dynamics of the thrombopoietin receptor in the plasma membrane].
Sakamoto A; Kato T; Funatsu T
Seikagaku; 2011 Oct; 83(10):912-9. PubMed ID: 22184884
[No Abstract] [Full Text] [Related]
13. Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains.
Lu X; Gross AW; Lodish HF
J Biol Chem; 2006 Mar; 281(11):7002-11. PubMed ID: 16414957
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin from beginning to end.
Hitchcock IS; Kaushansky K
Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199
[TBL] [Abstract][Full Text] [Related]
15. YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation.
Hitchcock IS; Chen MM; King JR; Kaushansky K
Blood; 2008 Sep; 112(6):2222-31. PubMed ID: 18487512
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin receptor-based protein-protein interaction screening (THROPPIS).
Horikawa M; Kakiuchi Y; Kashima D; Ogawa K; Kawahara M
Biotechnol Bioeng; 2022 Jan; 119(1):287-298. PubMed ID: 34708875
[TBL] [Abstract][Full Text] [Related]
17. C-Mannosylation of thrombopoietin receptor (c-Mpl) regulates thrombopoietin-dependent JAK-STAT signaling.
Sasazawa Y; Sato N; Suzuki T; Dohmae N; Simizu S
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):262-8. PubMed ID: 26505790
[TBL] [Abstract][Full Text] [Related]
18. gp130 activation is regulated by D2-D3 interdomain connectivity.
Schütt A; Zacharias M; Schneider N; Horn S; Grötzinger J; Rose-John S; Schmidt-Arras D
Biochem J; 2013 Mar; 450(3):487-96. PubMed ID: 23294003
[TBL] [Abstract][Full Text] [Related]
19. Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.
Elf S; Abdelfattah NS; Chen E; Perales-Patón J; Rosen EA; Ko A; Peisker F; Florescu N; Giannini S; Wolach O; Morgan EA; Tothova Z; Losman JA; Schneider RK; Al-Shahrour F; Mullally A
Cancer Discov; 2016 Apr; 6(4):368-81. PubMed ID: 26951227
[TBL] [Abstract][Full Text] [Related]
20. Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists.
Krause S; Schmoldt HU; Wentzel A; Ballmaier M; Friedrich K; Kolmar H
FEBS J; 2007 Jan; 274(1):86-95. PubMed ID: 17147697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
